EMERGING TESTS

Researchers Develop First Multiplex Test for Tick-Borne Disease Detection

Researchers have developed the first multiplex array for diagnosis of tickborne diseases, according to a study published online Feb. 16 in Nature Scientific Reports. The TBD-Serochip can … [Read more...]

INDUSTRY TRENDS

Evidence for Liquid Biopsy Lacking, Expert Panel Finds

There is not enough evidence, currently, to support the routine adoption of liquid biopsy tests for any of its promising clinical uses, according to a joint review published March 1 in both the … [Read more...]

EMERGING TESTS

SIDs Results From Genetic Heart Disease Less Than Previously Thought

The vast majority of sudden infant death syndrome (SIDS) cases are not the result of genetic heart diseases (GHDs) or a single genetic cause, according to a study published March 12 in the Journal of … [Read more...]

PRECISION MEDICINE

Dermatology Conference Highlights Gene Expression Tests for Skin Cancer

Several companies presented findings at the American Academy of Dermatology's annual meeting (Feb. 16-18, San Diego) indicating that gene expression profiling is making inroads in clinical dermatology … [Read more...]

EMERGING TESTS

Genotype-Matched Diets Don’t Aid Weight Loss

As most people who have ever tried dieting know, there is no single diet strategy that is consistently superior to others for the general population. Some have suggested that genotype or … [Read more...]

EMERGING TESTS

FDA Set Record in 2017 for Targeted Therapy Approvals

For the he fourth consecutive year, targeted therapies accounted for more than 20 percent of all new drug approved by the U.S. Food and Drug Administration (FDA), according to the Personalized … [Read more...]

TESTING TRENDS

Molecular Testing Increasingly Adopted for Skin Cancer Diagnosis

Dermatopathologists are increasingly using molecular testing for diagnosis of skin cancer samples. Yet, this adoption remains more concentrated in academic medical centers and high-volume clinical … [Read more...]

EMERGING TESTS

FDA Approves First Objective Blood Test for Concussion Evaluation

The U.S. Food and Drug Administration (FDA) recently approved the first blood test to evaluate concussions in adults. The Banyan Brain Trauma Indicator (Banyan Biomarkers; Alachua, Fla.) improves upon … [Read more...]

PRECISION MEDICINE

Study Shows Progress Towards a Blood-Based, Multi-Cancer Screen

A blood-based screening test capable of detecting multiple forms of early cancer just took one step closer to becoming a reality. A study published Jan. 18 in Science highlights the use of the blood … [Read more...]

EMERGING TESTS

Penicillin Skin Testing Can Delabel Misidentified Allergic Patients

In an era of growing concerns over antibiotic stewardship, there is renewed interest in delabeling misidentified penicillin allergies as part of quality improvement efforts. Most patients who report … [Read more...]


(-0000g2)